Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) Short Interest Update

Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) was the recipient of a significant growth in short interest in the month of July. As of July 31st, there was short interest totaling 296,924 shares, a growth of 417.6% from the July 15th total of 57,363 shares. Based on an average daily volume of 19,111,558 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.6% of the shares of the company are short sold.

Zhengye Biotechnology Price Performance

NASDAQ:ZYBT opened at $1.61 on Wednesday. Zhengye Biotechnology has a one year low of $0.62 and a one year high of $13.08. The company has a quick ratio of 0.82, a current ratio of 1.14 and a debt-to-equity ratio of 0.03. The firm’s fifty day moving average is $1.20 and its two-hundred day moving average is $1.01.

Wall Street Analyst Weigh In

Separately, Weiss Ratings upgraded shares of Zhengye Biotechnology from a “sell (d-)” rating to a “sell (d)” rating in a report on Monday, July 20th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has a consensus rating of “Sell”.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. XTX Topco Ltd raised its holdings in Zhengye Biotechnology by 71.4% in the 4th quarter. XTX Topco Ltd now owns 59,286 shares of the company’s stock worth $68,000 after purchasing an additional 24,697 shares during the period. WINTON GROUP Ltd lifted its stake in Zhengye Biotechnology by 193.8% in the 4th quarter. WINTON GROUP Ltd now owns 63,297 shares of the company’s stock valued at $73,000 after buying an additional 41,750 shares in the last quarter. Millennium Management LLC purchased a new position in Zhengye Biotechnology in the 3rd quarter valued at about $38,000. Citadel Advisors LLC acquired a new stake in Zhengye Biotechnology in the 3rd quarter worth about $31,000. Finally, Jane Street Group LLC acquired a new stake in Zhengye Biotechnology in the 2nd quarter worth about $1,158,000.

About Zhengye Biotechnology

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.